Clovis Oncology, Inc.·4

Oct 15, 4:19 PM ET

BLAIR JAMES C 4

4 · Clovis Oncology, Inc. · Filed Oct 15, 2018

Insider Transaction Report

Form 4
Period: 2018-10-11
BLAIR JAMES C
Director10% Owner
Transactions
  • Award

    Stock Option (Right to buy)

    2018-10-11+14,77014,770 total
    Exercise: $27.92Exp: 2028-10-11Common Stock (14,770 underlying)
Footnotes (1)
  • [F1]The option vests over 12 months in equal monthly installments on each monthly anniversary of the date of grant, beginning on 11/11/2018 and ending on 10/11/2019.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT